AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/03/2024 | Press release | Distributed by Public on 05/02/2024 23:25
Please select the service you want to use:
Smartlinks | Orkla ASA | Company News | Top Company News | Manufacturing | Food Industry | Securities Issuers | Food Processing Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Stuttgart Stock Exchange | Euronext Oslo | OTC Markets | BX Swiss | Tradegate Exchange | Nasdaq Stockholm | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Aquis Exchange | SIGMA X MTF | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact